Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This is a non-randomized, phase II, open label study of postoperative current
chemoradiotherapy for high-risk malignant salivary gland tumors of head and neck.The primary
purpose of this study is to evaluate the efficacy and safety of concurrent chemoradiotherapy
in these patients.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University